Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share Attributable to Common Stock - Schedule of Outstanding Shares of Common Stock Equivalents (Details)

v3.24.1.1.u2
Net Loss per Share Attributable to Common Stock - Schedule of Outstanding Shares of Common Stock Equivalents (Details) - shares
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents (in shares) 147,707 147,707
Non-vested restricted stock awards    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents (in shares) 1,246,528 1,974,828
Non-vested restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents (in shares) 2,631,384 1,274,603
Common stock warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents (in shares) 240,100 240,100
Convertible debt    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents (in shares) 583,333 0